[Form 4] Robinhood Markets, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Jeffrey Tsvi Pinner, Chief Technology Officer of Robinhood Markets, Inc. (HOOD), reported a sale of 5,865 shares of Class A common stock on 09/05/2025 at a weighted-average price of $99.8319 per share under a Rule 10b5-1 trading plan adopted November 11, 2024. After the reported dispositions, the filing shows Mr. Pinner beneficially owned 23,680 shares. The form was signed by an attorney-in-fact on 09/09/2025 and includes an offer to provide full trade-level details on request.
Positive
- Sale executed under a Rule 10b5-1 plan, indicating trades were pre-scheduled and compliant with insider trading rules
- Weighted-average price disclosed ($99.8319) and price range provided ($96.39 to $105.82), offering execution transparency
- Reporting person offers to provide full trade-level details on request, enhancing disclosure transparency
Negative
- Insider sale of 5,865 shares reduces the reporting person's stake to 23,680 shares
- Form shows disposition (S) rather than acquisition, which some investors view as negative even if pre-planned
Insights
TL;DR: CTO sold a small number of shares under a pre-established 10b5-1 plan; ownership remains in the mid-tens of thousands.
The filing documents a routine insider sale executed pursuant to a Rule 10b5-1 plan, which typically indicates trades were pre-scheduled and not opportunistic. The weighted-average price of $99.8319 reflects execution across prices from $96.39 to $105.82. The remaining 23,680 shares represent the reporter's continuing equity stake; the filing does not disclose options or other derivative positions. This is a transaction disclosure rather than an operational or financial update of the company.
TL;DR: Sale was conducted under a documented 10b5-1 plan, and the filer offers transparency on trade-level details.
The reporting indicates adherence to insider trading governance: the 10b5-1 plan adoption date is provided and the filer commits to supplying detailed trade information on request. The signature is by an attorney-in-fact, consistent with authorized filing practices. There are no disclosures here of policy breaches, adverse events, or changes in role; the filing is a compliance-driven disclosure of a single non-derivative sale.